iShares Biotechnology ETF Rating $192.06 -5.28 (-2.68%) As of 07/10/2026 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.70Holdings in IBB have an aggregate rating of Moderate Buy based on 527 analyst ratings issued in the past year covering 25 companies (64.7% of the portfolio).IBB Aggregate Price Target$192.06High Prediction$192.06Average Prediction$192.06Low Prediction$192.06Holdings in IBB have an aggregate price target of $192.06 and a range of $192.06 to $192.06 covering 25 companies (64.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.10%VRTXVertex Pharmaceuticals$485.39-2.2%3.8091 of 5 stars2.84$557.09 14.8%25Trending NewsAnalyst ForecastInsider Trade7.81%AMGNAmgen$363.39-0.1%4.0557 of 5 stars2.43$355.73 -2.1%30Positive NewsAnalyst Forecast6.82%GILDGilead Sciences$129.83-3.7%4.8401 of 5 stars2.90$159.04 22.5%29Analyst Forecast4.92%REGNRegeneron Pharmaceuticals$664.52-0.5%4.6684 of 5 stars2.70$787.67 18.5%27Positive NewsAnalyst ForecastInsider Trade3.68%ARGXargenex$877.62-3.5%4.4203 of 5 stars2.92$1,037.61 18.2%24Analyst Forecast3.13%ALNYAlnylam Pharmaceuticals$298.76-4.5%4.1439 of 5 stars2.85$461.05 54.3%26Trending NewsAnalyst DowngradeGap Up2.94%NTRANatera$269.95-4.2%2.0671 of 5 stars2.86$265.33 -1.7%22Analyst Forecast2.78%RVMDRevolution Medicines$186.88-2.2%1.9889 of 5 stars2.95$144.00 -22.9%22Analyst Forecast2.39%BIIBBiogen$199.15+0.1%3.7114 of 5 stars2.52$218.15 9.5%31Analyst Forecast2.16%ILMNIllumina$190.20-1.8%3.3141 of 5 stars2.33$150.44 -20.9%18Trending News2.05%MRNAModerna$68.27-10.8%1.8767 of 5 stars1.83$38.27 -43.9%18Trending NewsAnalyst ForecastOptions Volume1.81%ONCBeOne Medicines$298.70-1.4%4.694 of 5 stars2.80$391.38 31.0%15News CoverageAnalyst ForecastInsider Trade1.79%INSMInsmed$115.61-2.2%4.1383 of 5 stars2.96$211.00 82.5%25Analyst ForecastInsider Trade1.76%INCYIncyte$116.71-1.5%2.6685 of 5 stars2.36$108.20 -7.3%22Analyst Forecast1.75%UTHRUnited Therapeutics$547.06-1.0%4.4077 of 5 stars2.83$644.82 17.9%12Trending NewsAnalyst ForecastInsider Trade1.41%ROIVRoivant Sciences$35.97-2.3%1.4307 of 5 stars2.75$33.59 -6.6%121.29%NBIXNeurocrine Biosciences$177.11-1.9%4.4383 of 5 stars2.96$188.10 6.2%23Trending NewsAnalyst ForecastInsider Trade1.29%ASNDAscendis Pharma A/S$270.45-1.8%3.9876 of 5 stars3.00$295.67 9.3%19Analyst Forecast1.13%GMABGenmab A/S$29.00-2.6%4.5908 of 5 stars2.75$38.21 31.8%12High Trading Volume1.03%EXELExelixis$56.50-1.1%3.7386 of 5 stars2.35$47.93 -15.2%20Analyst Forecast1.00%IONSIonis Pharmaceuticals$58.25-9.4%3.6197 of 5 stars2.81$96.80 66.2%21Trending NewsAnalyst ForecastInsider TradeOptions VolumeAnalyst RevisionHigh Trading Volume0.98%MEDPMedpace$538.23+0.5%1.9713 of 5 stars2.07$469.17 -12.8%15News CoverageAnalyst Downgrade0.98%BBIOBridgeBio Pharma$85.89-4.7%2.5096 of 5 stars2.83$92.90 8.2%24Trending NewsOptions Volume0.87%MDGLMadrigal Pharmaceuticals$536.70-4.2%4.1706 of 5 stars2.78$687.93 28.2%18Positive News0.86%TECHBio-Techne$71.30+0.2%2.202 of 5 stars2.12$68.08 -4.5%17Analyst Downgrade This page (NASDAQ:IBB) was last updated on 7/11/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
